Ticker >

Natural Biocon (I) share price

Natural Biocon (India) Ltd.

BSE: 543207 SECTOR: Trading  7861   5   0

13.50
-0.08 (-0.59%)
BSE: Today, 03:33 PM

Price Summary

Today's High

₹ 13.85

Today's Low

₹ 13.4

52 Week High

₹ 14.85

52 Week Low

₹ 8.33

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

34.67 Cr.

Enterprise Value

34.43 Cr.

No. of Shares

2.57 Cr.

P/E

89.11

P/B

1.13

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  11.98

CASH

0.4 Cr.

DEBT

0.15 Cr.

Promoter Holding

9.36 %

EPS (TTM)

₹  0.15

Sales Growth

160.34%

ROE

1.48 %

ROCE

2.02%

Profit Growth

171.78 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year160.34%
3 Year∞%
5 Year3.76%

Profit Growth

1 Year171.78%
3 Year97.07%
5 Year-23.88%

ROE%

1 Year1.48%
3 Year0.68%
5 Year0.48%

ROCE %

1 Year2.02%
3 Year0.92%
5 Year0.7%

Debt/Equity

0.0126

Price to Cash Flow

164.79

Interest Cover Ratio

206.833333333333

CFO/PAT (5 Yr. Avg.)

0.0775022152694591

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 9.36 0.00
Jun 2024 21.22 0.00
Mar 2024 21.22 0.00
Dec 2023 21.22 0.00
Sep 2023 21.22 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company’s PEG ratio is 0.518012644637958.
  • The company has an efficient Cash Conversion Cycle of 88.800706024116 days.

 Limitations

  • Company has a poor ROE of 0.682157656699629% over the past 3 years.
  • Company has a poor ROCE of 0.924752787725285% over the past 3 years
  • The company is trading at a high EV/EBITDA of 74.7831.
  • Promoter stake has been decreased from 21.22% to 9.36%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Net Sales 0.27 3.24 2.16 11.37 0.99
Total Expenditure 0.22 3.1 2.07 11.24 0.89
Operating Profit 0.05 0.14 0.09 0.13 0.1
Other Income 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.05 0.14 0.09 0.13 0.1
Tax 0 0 0 0.07 0
Profit After Tax 0.05 0.14 0.09 0.06 0.1
Adjusted EPS (Rs) 0.05 0.12 0.08 0.05 0.09

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 0.45 0 0.13 0.48 1.25
Total Expenditure 0.34 0.03 0.13 0.39 1.01
Operating Profit 0.11 -0.03 0 0.09 0.25
Other Income 0.01 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.12 -0.03 0 0.09 0.25
Tax 0.05 0 0 0.02 0.07
Net Profit 0.07 -0.03 0 0.07 0.18
Adjusted EPS (Rs.) 0.06 -0.03 0 0.06 0.16

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 11.37 11.37 11.37 11.37 11.37
Total Reserves 0.64 0.61 0.61 0.68 0.86
Borrowings 0 0 0 0 0
Other N/C liabilities 0 0 0 0 0
Current liabilities 1 0.73 0.39 0.25 1.29
Total Liabilities 13.02 12.71 12.38 12.3 13.52
Assets
Net Block 0 0 0 0.01 0.01
Capital WIP 3.29 3.29 3.29 3.29 3.29
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 7.86 7.54 7.3 8.07 8.07
Other N/C Assets 0 0 0 0 0
Current Assets 1.87 1.88 1.79 0.93 2.15
Total Assets 13.02 12.71 12.38 12.3 13.52
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.12 -0.03 0 0.09 0.25
Adjustment 0 0 0 0 0
Changes in Assets & Liabilities -0.93 0.18 0.32 0.11 0.03
Tax Paid -0.05 0 0 -0.01 -0.07
Operating Cash Flow -0.86 0.15 0.32 0.19 0.21
Investing Cash Flow 0 0 0 0 0
Financing Cash Flow 0.75 -0.14 -0.32 -0.02 -0.02
Net Cash Flow -0.11 0.01 0 0.17 0.19

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 21.22 21.22 21.22 21.22 9.36
gitaben sureshbhai shah 7.48 7.48 7.47 7.47 3.30
priyakant upadhyay 6.88 6.88 6.88 6.88 3.03
tarlika p. upadhyay 6.87 6.87 6.87 6.87 3.03
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 78.78 78.78 78.78 78.78 90.64
aarnah capital advisors p... - - - - 9.70
atul jain huf - 2.59 2.59 2.59 1.14
aventez media & technolog... - - - - 9.70
copo holdings private lim... - - - - 9.70
jigish bhanushanker trive... 7.74 7.74 7.74 7.74 3.41
jigna pratik zaveri 2.31 2.31 2.31 2.31 1.02
mndm business point priva... - - - - 9.70
rich pockets online servi... - - - - 9.31
satyasur marketing privat... - - - - 7.76
manish rameshbhai patel 1.28 1.28 1.28 1.28 -
rupa kumari 2.62 2.62 1.55 1.55 -
sanjay dhaked 3.25 3.25 3.61 3.61 -
sanjeev maheswariprasad p... 1.35 1.27 1.25 1.25 -
suman chepuri - - 1.83 1.83 -
amit pitamsingh verma 3.41 1.83 - - -
jigarkumar dahyalal patel... 1.67 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Natural Biocon (I) - Quaterly Results14 Aug 2024, 6:33PM Natural Biocon (I) - Quaterly Results12 Feb 2024, 5:25PM Natural Biocon (I) - Quaterly Results12 Feb 2024, 5:25PM Natural Biocon (I) - Quaterly Results7 Nov 2023, 1:15PM Natural Biocon (I) - Quaterly Results7 Nov 2023, 1:15PM Natural Biocon (I) - Quaterly Results7 Nov 2023, 1:15PM Natural Biocon (I) - Quaterly Results2 May 2023, 6:18PM Natural Biocon (I) - Quaterly Results2 May 2023, 6:18PM Natural Biocon (I) - Quaterly Results2 May 2023, 6:18PM Natural Biocon (India) informs about certificate27 Apr 2023, 4:33PM Natural Biocon (I) - Quaterly Results14 Feb 2023, 6:46PM Natural Biocon (India) informs about meeting updates1 Oct 2022, 3:55PM Natural Biocon (India) informs about outcome of AGM1 Oct 2022, 3:24PM Natural Biocon (India) informs about book closure 12 Sep 2022, 4:26PM Natural Biocon (I) - Quaterly Results8 Aug 2022, 8:13PM Natural Biocon (I) - Quaterly Results8 Aug 2022, 8:13PM Natural Biocon (India) informs about trading window closure1 Jul 2022, 12:17PM Natural Biocon (India) informs about outcome of board meeting27 May 2022, 5:07PM Natural Biocon (India) informs about resignation of CS17 May 2022, 4:50PM Natural Biocon (I) - Quaterly Results17 May 2022, 12:40PM Natural Biocon (India) informs about outcome of independent directors meet24 Mar 2022, 4:04PM Natural Biocon (I) - Quaterly Results10 Feb 2022, 2:52PM Natural Biocon (I) - Quaterly Results10 Feb 2022, 2:52PM Natural Biocon (I) - Quaterly Results10 Feb 2022, 2:52PM Natural Biocon (India) informs about compliance certificate25 Oct 2021, 12:53PM Natural Biocon (India) informs about outcome of board meeting8 Oct 2021, 4:10PM Natural Biocon (India) informs about outcome of board meeting8 Oct 2021, 2:27PM Natural Biocon (I) - Quaterly Results8 Oct 2021, 12:16PM Natural Biocon (I) - Quaterly Results8 Oct 2021, 12:16PM Natural Biocon (I) - Quaterly Results8 Oct 2021, 12:16PM Natural Biocon (India) submits half yearly compliance certificate30 Apr 2021, 1:27PM Natural Biocon (India) informs about compliance certificate21 Apr 2021, 3:28PM Natural Biocon (India) informs about scrutinizer's report28 Sep 2020, 3:54PM

Natural Biocon (I) Stock Price Analysis and Quick Research Report. Is Natural Biocon (I) an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Natural Biocon (I) stock price today is Rs 13.5. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Natural Biocon (I) . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Natural Biocon (I) has a PE ratio of 89.1089108910891 which is high and comparatively overvalued .

  • Share Price: - The current share price of Natural Biocon (I) is Rs 13.5. One can use valuation calculators of ticker to know if Natural Biocon (I) share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Natural Biocon (I) has ROA of 1.3875814942649 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Natural Biocon (I) has a Current ratio of 1.67127651309145 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Natural Biocon (I) has a ROE of 1.47519716656714 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Natural Biocon (I) has a Debt to Equity ratio of 0.0126 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Natural Biocon (I) has reported revenue growth of 160.336239103362 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Natural Biocon (I) for the current financial year is 19.7879295224428 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Natural Biocon (I) is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Natural Biocon (I) is Rs 0.1515 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Natural Biocon (I) in Ticker for free. Also, one can get the intrinsic value of Natural Biocon (I) by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Natural Biocon (I)
X